<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05610644</url>
  </required_header>
  <id_info>
    <org_study_id>275081</org_study_id>
    <nct_id>NCT05610644</nct_id>
  </id_info>
  <brief_title>Impact of Time Restricted Feeding on Daily Protein Requirements</brief_title>
  <official_title>Impact of Time Restricted Feeding on Daily Protein Requirements</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Arkansas</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Arkansas</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators aim to assess 24-hour protein kinetics at two different levels of protein&#xD;
      intake: 0.8 (RDA) and 1.6g/kg/day (2RDA) during a normal dietary (TRAD) and a time restricted&#xD;
      feeding (TRF) pattern in older adults.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators aim to assess 24-hour protein kinetics at two different levels of protein&#xD;
      intake: 0.8 (RDA) and 1.6g/kg/day (2RDA) during a normal dietary (TRAD) and a time restricted&#xD;
      feeding (TRF) pattern in older adults. Individuals in the TRF pattern will only consume food&#xD;
      during a 6-hour eating period and fast for the remaining 18 hours. Individuals in the TRAD&#xD;
      pattern will consume isocaloric and isonitrogenous (RDA or 2RDA) diet but consume an&#xD;
      all-beef-breakfast. Participants will consume oral stable isotopes to measure muscle protein&#xD;
      synthesis (MPS), whole-body muscle protein breakdown (MPB), and whole-body protein balance&#xD;
      (WBPB). Appropriate muscle, blood samples, and urine will be collected throughout a 24-hour&#xD;
      metabolic trial following a 2-day controlled diet.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 29, 2023</start_date>
  <completion_date type="Anticipated">March 2024</completion_date>
  <primary_completion_date type="Anticipated">March 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Whole-body protein balance</measure>
    <time_frame>24 hours</time_frame>
    <description>Volume of net protein produced per unit of time</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Nutrition Disorders in Old Age</condition>
  <arm_group>
    <arm_group_label>TRF of RDA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A time-restricted model of consumption of the RDA of protein/day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TRAD of RDA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A typical American dietary ingestion pattern of the RDA of protein/day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TRF of 2RDA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A time-restricted model of consumption of twice the RDA of protein/day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TRAD of 2RDA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A typical American dietary ingestion pattern of twice the RDA of protein/day.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>isocaloric, isonitrogenous meals</intervention_name>
    <description>Participants will eat prepared study meals for 3 days that have either the RDA of protein per day or twice the RDA of protein per day.</description>
    <arm_group_label>TRAD of 2RDA</arm_group_label>
    <arm_group_label>TRAD of RDA</arm_group_label>
    <arm_group_label>TRF of 2RDA</arm_group_label>
    <arm_group_label>TRF of RDA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Men and women ages 50-75 years.&#xD;
&#xD;
          2. BMI 20-30 kg/m2 inclusive.&#xD;
&#xD;
          3. Capable of providing informed consent.&#xD;
&#xD;
          4. COVID-19 negative and/or asymptomatic&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Subject who does not/will not eat animal protein sources.&#xD;
&#xD;
          2. Body mass index &lt;20 or &gt;30.&#xD;
&#xD;
          3. Hemoglobin &lt;10g/dL at screening.&#xD;
&#xD;
          4. Platelets &lt;150,000/uL at screening.&#xD;
&#xD;
          5. History of diabetes.&#xD;
&#xD;
          6. History of chemotherapy or radiation therapy for cancer in the 6 months prior to&#xD;
             enrollment.&#xD;
&#xD;
          7. History of gastrointestinal bypass/reduction surgery.&#xD;
&#xD;
          8. History of a chronic inflammatory disease (e.g. what?)&#xD;
&#xD;
          9. Currently receiving androgen (e.g., testosterone) or anabolic (e.g., GH, IGF-I)&#xD;
             therapy.&#xD;
&#xD;
         10. Currently using prescription blood thinning medications.&#xD;
&#xD;
         11. Currently using corticosteroid medications.&#xD;
&#xD;
         12. Unable or unwilling to suspend aspirin use for 7 days prior to Visit 3.&#xD;
&#xD;
         13. Unwilling to avoid using protein or amino-acid supplements during participation.&#xD;
&#xD;
         14. Subjects who are unwilling to fast overnight.&#xD;
&#xD;
         15. Participating in &gt;200 minutes/week of vigorous exercise and/or &gt;4 days/week of&#xD;
             resistance training.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Church</last_name>
    <role>Principal Investigator</role>
    <affiliation>UAMS (University of Arkansas for Medical Sciences)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>David Church</last_name>
    <phone>501-526-5769</phone>
    <email>dchurch@uams.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Scott Schutzler</last_name>
    <phone>501-526-5734</phone>
    <email>SESchutzler@uams.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Arkansas for Medical Sciences</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Church, Ph.D.</last_name>
      <phone>501-526-5769</phone>
      <email>DChurch@uams.edu</email>
    </contact>
    <contact_backup>
      <last_name>Scott Schutzler, RN</last_name>
      <phone>5015265734</phone>
      <email>seschutzler@uams.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2023</verification_date>
  <study_first_submitted>November 2, 2022</study_first_submitted>
  <study_first_submitted_qc>November 2, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2022</study_first_posted>
  <last_update_submitted>April 6, 2023</last_update_submitted>
  <last_update_submitted_qc>April 6, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">April 10, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nutrition Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

